P288 Is it safe to discontinue long-term trastuzumab containing therapy after radiological complete response (rCR) in metastatic HER-2 positive breast cancer (MBC)? von Calamac, M., Stanic, N., Djurmez, O., Dimitrijevic, M., Vukosavljevic, J., Serovic, K., Oblakovic-Babic, J., Minic, I., Bozovic-Spasojevic, I.

Volltext

P126 Pathological complete response after neoadjuvant chemotherapy in patients with HER2 low and HER2 0 early breast cancer (eBC) – experience from Institute for Oncology and Radio... von Djurmez, O., Calamac, M., Stanic, N., Dimitrijevic, M., Vukosavljevic, J., Serovic, K., Oblakovic-Babic, J., Minic, I., Gavrilovic, D., Bozovic-Spasojevic, I.

Volltext

Our experience with COVID-19 infection in oncology patients von Djurmez, O., Calamac, M., Dimitrijevic, M., Serovic, K., Oblakovic-Babic, J., Minic, I., Tomasevic, Z., Bozovic-Spasojevic, I.

Volltext

Long-term trastuzumab treatment in HER2 positive metastatic breast cancer von Calamac, M., Minic, I., Tomasevic, Z., Oblakovic-Babic, J., Serovic, K., Djurmez, O., Dimitrijevic, M., Bozovic-Spasojevic, I.

Volltext

Tolerability of luteinising hormone releasing hormoneanalogue (LHRH) therapy in patients with early breast cancer treatedat the Institute for Oncology and Radiology of Serbia (IORS... von Dimitrijevic, M., Calamac, M., Djurmez, O., Šerovic, K., Minic, I., Oblakovic, J., Tomaševic, Z., Bozovic Spasojevic, I.

Volltext

Effect of symptom interval and demographic characteristics on initial stage of malignant tumors in children: PS068 von Grujicic, R, Djurmez, O, Trkulja, M, Lazić, J, Bjelić, M

Volltext

P175 - Tolerability of luteinising hormone releasing hormoneanalogue (LHRH) therapy in patients with early breast cancer treatedat the Institute for Oncology and Radiology of Serbi... von Dimitrijevic, M., Calamac, M., Djurmez, O., Šerovic, K., Minic, I., Oblakovic, J., Tomaševic, Z., Bozovic Spasojevic, I.

Volltext

P157 - Long-term trastuzumab treatment in HER2 positive metastatic breast cancer von Calamac, M., Minic, I., Tomasevic, Z., Oblakovic-Babic, J., Serovic, K., Djurmez, O., Dimitrijevic, M., Bozovic-Spasojevic, I.

Volltext

P174 - Our experience with COVID-19 infection in oncology patients von Djurmez, O., Calamac, M., Dimitrijevic, M., Serovic, K., Oblakovic-Babic, J., Minic, I., Tomasevic, Z., Bozovic-Spasojevic, I.

Volltext

Effect of symptom interval and demographic characteristics on initial stage of malignant tumors in children von Grujicic, R., Djurmez, O., Trkulja, M., Lazić, J., Bjelić, M.

Volltext